•  
  •  
  •  
  •  

2025-12-23 13:07:33

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  5Star

Stock Report

  • Samskara Bagru Commences Full-Swing Construction of 225 Rooms Spread Over 7 acres of Prime Land in Jaipur
  • HMA Agro Industries Ltd recognized as a 5 Star Export House by DGFT
  • Spectrum Foods Ltd. Signs Non-Binding LOI With IHG for Pushkar Project
  • Spectrum Foods Ltd - Pushkar Resort Construction Update
  • Royal Orchid Hotels Ltd expands in Rajasthan, announces signing of luxury Resort in Chittorgarh
  • Sunteck Realty Ltd receives the prestigious 5-star rating from GRESB in its second year of submission with a strong score of 95
  • Ministry of Coal awards a '5 Star' rating to GHCL Limited's Khadsaliya Lignite Mines
  • Brookfield India Real Estate Trust receives a 5-star rating from GRESB in its first year of submission
  • Mindspace REIT receives 5 Star GRESB Rating in Development Benchmark
  • India's Safest Vehicle Remains a Mahindra

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024